Analysis

Narrowing the hunt for nanoparticles

Narrowing the hunt for nanoparticles

Cancergraph: a desperately needed link between patient and clinical trial

Cancergraph: a desperately needed link between patient and clinical trial

Illuminating drug discovery by mapping all known drugs

Illuminating drug discovery by mapping all known drugs

Turning to turmeric: exciting drug candidate or another dead end?

Turning to turmeric: exciting drug candidate or another dead end?

BlueRock Therapeutics: Ontario’s home-grown stem cell contender

BlueRock Therapeutics: Ontario’s home-grown stem cell contender

Using shark antibodies to treat Alzheimer’s disease

Using shark antibodies to treat Alzheimer’s disease

Medicines Discovery Catapult: improving collaborative drug discovery in the UK

Medicines Discovery Catapult: improving collaborative drug discovery in the UK

Therapeutic orphans: child-friendly drugs and the quest for adherence

Therapeutic orphans: child-friendly drugs and the quest for adherence

The Hive: new incubator makes a beeline for non-traditional pharma companies

The Hive: new incubator makes a beeline for non-traditional pharma companies

BenevolentAI: using artificial intelligence to speed up drug discovery

BenevolentAI: using artificial intelligence to speed up drug discovery

Pharma Technology Focus – Issue 55

Pharma Technology Focus – Issue 55

After the cure: addressing side effects in childhood cancer patients

After the cure: addressing side effects in childhood cancer patients

Antibiotic resistance: the race for the prize

Antibiotic resistance: the race for the prize

Could activating telomerase trick the ageing process?

Could activating telomerase trick the ageing process?

Back to biology: how BERG is using artificial intelligence to tackle cancer

Back to biology: how BERG is using artificial intelligence to tackle cancer

IBM’s lab on a chip breakthrough seeks out cancers origin

IBM’s lab on a chip breakthrough seeks out cancers origin

US Precision Medicine Initiative gears up for a massive e-health drive

US Precision Medicine Initiative gears up for a massive e-health drive

Is the stage set for global drug price regulation?

Is the stage set for global drug price regulation?

August's top stories: Pfizer-AstraZeneca $1.5bn deal, Cinven buys Bioclinica for $1.4bn

August's top stories: Pfizer-AstraZeneca $1.5bn deal, Cinven buys Bioclinica for $1.4bn

At long last, a good year for Australia’s pharma industry

At long last, a good year for Australia’s pharma industry

Pharma Technology Focus – Issue 50

Pharma Technology Focus – Issue 50
cachename:Featurescachekey:rd-137342983_989685772_rd-1665407042_727740091_rd-488908060_1460672566_ap1460672566_727740091_-1939411708